Regal Tribune

Wednesday, March 3, 2021
Log in
  • National News
  • Business
  • Technology
  • Science
  • Health
  • About Regal Tribune

Pages

  • About Regal Tribune
  • Body of Woman Discovered in Gwinnett Place Mall Identified
  • Compulsory Vaccines for Children
  • Contact Us
  • High Tides Are the New Danger in U.S. States
  • Homepage
  • Our Team
  • Privacy Policy GDPR
  • Terms of Use

Recent Posts

  • Canadian Teen Dies on School Trip from Toxic Shock Syndrome Jun 29, 2018
  • Unesco Removes the Belize Coral Reef from Its List of Endangered Sites Jun 28, 2018
  • Tonight, the Blood Moon Coincides with the Longest Lunar Eclipse of the Century Jun 27, 2018
  • People Are Paying Hundreds of Dollars Just to Own Official Fortnite Disc Copies Jun 27, 2018
  • Researchers Reassess the Fermi Paradox, Showing We’re Probably Alone in the Universe (Study) Jun 26, 2018
  • The Latest Xbox Update Might Bring Keyboard and Mouse Support on the Console Jun 26, 2018
  • Researchers Invent Miraculous Plaster that Effectively Treats Oral Ulcers Jun 25, 2018

FDA Rejects Drug for Duchenne’s Muscular Dystrophy

Jan 16, 2016 By Jose Buttner 1 Comment

Email, RSS Follow
"wheelchair"

If effective, the drug has the potential to save thousands of lives

The FDA rejects drug for Duchenne’s Muscular Dystrophy (DMD). Eteplirsen is the name of the drug developed by Serapta which has been rejected by the FDA at only a week after kyndrisa, a similar drug developed by BioMarin has also been rejected.

The neurology division of the FDA has reviewed the eteplirsen and concluded that the amount of dystrophin it produces is insignificant to actually improve the condition of the patients. Dystrophin is the critical protein missing from the muscles of boys suffering of DMD.

DMD is a disease affecting boys, who become dependent of wheelchairs before the teenage years and killing them on average at the age of 25. The disease is affecting over 15,000 boys in the United States and until now there is no medicine which can at least slow its progression.

The hundreds of thousands of patients were waiting for Sarepta and BioMarin to release their drugs on the market, hoping they will be provided with the necessary dystrophin lacking from their bodies.

Next Friday an advisory committee formed from outside experts will hear the FDA’s report along with testimonies from Serepta and DMD experts and patients. After hearing all the parts the panel will issue their recommendations about eteplirsen to the FDA that might change its decision and finally approve the drug.

In most of the cases the FDA accepts recommendations made by the advisory panel but it is not obligated to. The agency will decide whether or not they will grant accelerated approval to the new drug by the end of February.

Pharmaceutical companies can request accelerated approval for certain drugs developed to respond to serious unmet needs. This procedure implies skipping the extensive clinical trials usually requested by the FDA.

The FDA declared that even if they are ready to show flexibility with respect to this devastating illness without any treatment available it cannot give approval for a drug without substantial evidence of effectiveness.

Calculations show that the effectiveness of the drug has been calculated to an average of only 0.9 of dystrophin increase after 180 weeks of treatment. It is not yet known the level required for clinical significance but experts say it should be a lot more than 1 percent.

However, even if the drug won’t be approved this year it still has chances to get approval in 2017 as Sarepta has already begun the third phase of the drug’s study which is expected to produce results by the end of 2017.

 Image source: freeimages

Email, RSS Follow

Filed Under: Health Tagged With: BioMarin, Eteplirsen, FDA, FDA Rejects Drug for Duchenne’s Muscular Dystrophy, Serapta

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 11 other subscribers

Recent Articles

Starbucks coffee.

California Family to Sue Starbucks over Drinking Coffee with Blood

Feb 11, 2018 By Benjamin Teh Leave a Comment

uber app

Portland Officials Learned Uber Activated Software to Deceive Ride Service Regulators

Sep 16, 2017 By Jose Buttner Leave a Comment

tesla model s

Tesla’s Free Software Upgrade for Drivers Affected by Irma to Expire on Saturday

Sep 12, 2017 By Jose Buttner Leave a Comment

hurricane aftermath

Companies Assess the Economic Toll of Two Hurricanes Hitting the U.S.

Sep 11, 2017 By Lori Martinez Leave a Comment

chipotle restaurant

Chipotle Announced Nationwide Launch for Famous Cheese Sauce, Queso

Sep 6, 2017 By Lori Martinez Leave a Comment

bitcoin coins

China Is the First Nation to React to Initial Coin Offerings

Sep 4, 2017 By Benjamin Teh Leave a Comment

people sheltering from flood

Best Buy Gives Its Apologies for Water Price Gouging after Hurricane Harvey

Sep 2, 2017 By Graziella Paone Leave a Comment

uber driver

Uber Will Quit Surveillance Feature after Riders End Their Trips

Aug 31, 2017 By Benjamin Teh Leave a Comment

uber car

Uber Introduces New Flexible Driver Benefits

Aug 24, 2017 By Graziella Paone Leave a Comment

mountain view

Interior Department Kills Study on Health Hazards of Appalachian Mountaintop Removal Coal Mine

Aug 23, 2017 By Jose Buttner Leave a Comment

volkswagen minibus

Volkswagen Is Bringing Back the Sassy ID Buzz Minibus in Electric Version

Aug 21, 2017 By Benjamin Teh Leave a Comment

howard schultz interview

Starbucks CEO Speaks out about Charlottesville Violence

Aug 19, 2017 By Jose Buttner Leave a Comment

michael o'leary

Ryanair CEO Opposes Collaboration between Lufthansa and Insolvent Rival Air Berlin

Aug 18, 2017 By Lori Martinez Leave a Comment

aldi logo

Aldi Distances Itself from Competitors with New Grocery Delivery System

Aug 14, 2017 By Jose Buttner Leave a Comment

Related Articles

  • Colony of green bacteria

    Canadian Teen Dies on School Trip from Toxic Shock Syndrome

    Jun 29, 2018
  • Five plasters placed on a dark blue textile surface

    Researchers Invent Miraculous Plaster that Effectively Treats Oral Ulcers

    Jun 25, 2018
  • Old person holding their hands on their legs

    Parkinson’s Medication Might Activate Compulsive Behavior, Turning People into Sex Addicts

    Jun 21, 2018
  • Black overweight Labrador sitting on a carpet

    Overweight Dogs Might Teach Researchers How to Deal with Obesity (Study)

    Jun 18, 2018
  • Colorful elephant drawings on LSD stamps

    Psychedelic Drugs Might Reverse the Effects of Depression (Study)

    Jun 14, 2018
  • Thermometer placed on top of a pile of prescription drugs

    More Americans Are Taking Prescription Drugs with Anxiety and Depression as Side Effects (Study)

    Jun 13, 2018
  • Child studying at night using a poor light source

    Researchers Identify Strong Link Between Education and Poor Vision (Study)

    Jun 7, 2018
  • Pomegranate half with dark red arils inside

    Australian Woman Dies from Hepatitis A after Eating a Frozen Pomegranate

    Jun 6, 2018
  • Baby feet sticking out of a fluffy blanket

    Doctor who Decapitated Baby during Breech Birth Pronounced Guilty

    Jun 5, 2018
  • Intricate eye makeup in shades of blue and green

    Australian Woman Is Left Nearly Blind After Not Removing Eye Makeup for 25 Years (Study)

    Jun 4, 2018

Categories

  • Business
  • Entertainment
  • Health
  • National News
  • Nature
  • Science
  • Technology
  • U.S.

Copyright © 2021RegalTribune.com

About · Privacy Policy · Terms of Use · Contact

This website uses cookies to ensure you get the best experience on our website. Learn more.